19 September 2016
Fifteen new peptide derivatives of ɛ-aminocaproic acid (EACA) containing the known fragment –Ala–Phe–Lys– with an affinity for plasmin were synthesised in the present study. The synthesis was carried out a solid phase. The following compounds were synthesised: H–Phe–Lys–EACA–X, H– d-Ala–Phe–Lys–EACA–X, H–Ala–Phe–Lys–EACA–X, H– d-Ala–Phe–EACA–X and H–Ala–Phe–EACA–X, where X = OH, NH 2 and NH–(CH 2) 5–NH 2. All peptides, except for those containing the sequence H–Ala–Phe–EACA–X, displayed higher inhibitory activity against plasmin than EACA. The most active and selective inhibitor of plasmin was the compound H– d-Ala–Phe–Lys–EACA–NH 2 which inhibited the amidolytic activity of plasmin (IC 50 = 0.02 mM), with the antifibrinolytic activity weaker than EACA. The resulting peptides did not affect the viability of fibroblast cells, colon cancer cell line DL D-1, breast MCF-7 and MDA-MB-231 cell lines.